 |
 |
 |
 |
 |
 |
 |
 |
||||||
 |
 |
 |
 |
 |
|
||
CARTICEPT MEDICAL™ ANNOUNCES $20 MILLION SERIES B FINANCING Carticept Medical, Inc., a developer of innovative products for the treatment of cartilage injuries and osteoarthritis, today announced that it has completed a $20 million Series B financing round. |
|
||||||
Cartiva SCI is designed to replace or repair worn or damaged cartilage. The proprietary implant mimics natural cartilage and is intended to maintain natural joint mechanics.
Learn More |
The Navigator DS is an integrated, computer-controlled fluid delivery system designed to automate delivery of medications and other fluids. |
||||||
 |
|
|
|||||
| Home | About Us | Products | Clinical Trials | News & Events | Contact Us | Privacy | Terms of Use | © 2010 Carticept Medical, Inc. All rights reserved. |